The data demonstrated that the upregulations of the mRNA expression levels of NLRP3, ASC, caspase1, IL-1β, and IL-18 were remarkably reversed in PSP treatment groups. This evidence concerns the gene IL18 and supranuclear palsy, progressive, 1.